Remedent Valuation
| REMI Stock | USD 0.0006 0.0001 20.00% |
Remedent seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Remedent from analyzing the company fundamentals such as Return On Equity of 0.042, shares outstanding of 20 M, and Operating Margin of 0.17 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Remedent's price fluctuation is out of control at this time. Calculation of the real value of Remedent is based on 3 months time horizon. Increasing Remedent's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Remedent is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Remedent Pink Sheet. However, Remedent's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.0E-4 | Real 3.82E-4 | Hype 4.17E-4 | Naive 6.93E-4 |
The intrinsic value of Remedent's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Remedent's stock price.
Estimating the potential upside or downside of Remedent helps investors to forecast how Remedent pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Remedent more accurately as focusing exclusively on Remedent's fundamentals will not take into account other important factors: Remedent Total Value Analysis
Remedent is at this time expected to have valuation of 3.36 M with market capitalization of 3.4 M, debt of 9.43 K, and cash on hands of 83.3 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Remedent fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.36 M | 3.4 M | 9.43 K | 83.3 K |
Remedent Investor Information
About 36.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Remedent recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 6th of June 2005. Based on the key indicators related to Remedent's liquidity, profitability, solvency, and operating efficiency, Remedent is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Remedent Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Remedent signifies not a very effective usage of assets in December.Remedent Ownership Allocation
Remedent owns a total of 20 Million outstanding shares. Remedent has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Remedent Profitability Analysis
The company reported the previous year's revenue of 401.9 K. Net Income was 131.86 K with profit before overhead, payroll, taxes, and interest of 171.15 K.About Remedent Valuation
An absolute valuation paradigm, as applied to Remedent Pink Sheet, attempts to find the value of Remedent based on its fundamental and basic technical indicators. By analyzing Remedent's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Remedent's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Remedent. We calculate exposure to Remedent's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Remedent's related companies.Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. The company was founded in 1986 and is headquartered in Ghent, Belgium. Remedent operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3 people.
8 Steps to conduct Remedent's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Remedent's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Remedent's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Remedent's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Remedent's revenue streams: Identify Remedent's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Remedent's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Remedent's growth potential: Evaluate Remedent's management, business model, and growth potential.
- Determine Remedent's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Remedent's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Remedent Pink Sheet analysis
When running Remedent's price analysis, check to measure Remedent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Remedent is operating at the current time. Most of Remedent's value examination focuses on studying past and present price action to predict the probability of Remedent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Remedent's price. Additionally, you may evaluate how the addition of Remedent to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |